Cargando…
Recurrence of proteinuria after cessation of tocilizumab in patients with AA amyloidosis secondary to FMF
There is no established treatment protocol for amyloid-A (AA) amyloidosis secondary to Familial Mediterranean Fever (FMF). Recently, we reported the efficacy of tocilizumab in 11 amyloidosis cases associated with FMF. In 2 patients of 11, we discontinued the tocilizumab administeration owing to the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medical Research and Education Association
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267750/ https://www.ncbi.nlm.nih.gov/pubmed/30071938 http://dx.doi.org/10.5152/eurjrheum.2018.17183 |